The NIMH Multimodal Treatment Study for Attention-Deficit Hyperactivity Disorder: Just say yes to drugs alone?

Canadian Journal of Psychiatry

Volumn 44, Issue 10, 1999, Pages 981-990

  Pelham Jr , William E ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Attention deficit hyperactivity disorder; Behavioural treatment; Medication management; Study design

Indexed keywords

PSYCHOTROPIC AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0343067123     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379904401004     Document Type: Review

References (31)

1. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, and others. National Institute of Mental Health collaborative multimodal treatment study of children with ADHD (MTA): design challenges and choices. Arch Gen Psychiatry 1997;54:865-70.
2. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, and others. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996;35:1304-13.
3. Hinshaw SP, March J, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, and others. Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. Journal of Attention Deficit Disorders 1997;1:217-34.
4. Richters JE, Arnold LE, Jensen PS, Abikoff H, Conners K, Greenhill LL, and others. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry 1995;34:987-1000.
5. Wells KC, Pelham WE, Kotkin RA, Swanson JM, Abikoff HB, Arnold LE, and others. NIMH collaborative multimodal treatment study of children with ADHD (MTA): psychosocial treatments, J Abnorm Child Psychol. Forthcoming.
6. MTA Cooperative Group. 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry. Forthcoming.
7. MTA Cooperative Group. Effects of comorbid anxiety disorder, family poverty, session attendance, and community medication on treatment outcome for attention-deficit hyperactivity disorder. Arch Gen Psychiatry. Forthcoming.
8. Pelham WE, Wheeler T, Chronis AM. Empirically supported psychosocial treatments for ADHD. J Child Clin Psychol 1998;27:189-204.
9. Swanson JM, McBurnett K, Christian DL, Wigal T. Stimulant medications and the treatment of children with ADHD. In: Ollendick TH, Prinz RJ, editors. Advances in Clinical Child Psychology. New York: Plenum Press; 1995. p 265-322.
10. Pelham WE. Pharmacological treatment for children with attention-deficit hyperactivity disorder. School Psychology Review 1993;22:199-227.
11. Pelham WE, Hoza B. Comprehensive treatment for ADHD: intensive summer treatment programs and follow-up. In Hibbs ED, Jensen PS, editors. Psychosocial treatments for child and adolescent disorders. Washington (DC): American Psychological Association; 1996. p 311-40.
12. Wilson GT. Manual-based treatments: the clinical application of research findings Behav Res Ther 1996:34:295-314.
13. Waltz J, Addis ME, Koerner K, Jaconbson NS. Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol 1993;61:620-30.
14. Sherman M, Hertzig ME. Prescribing practices of Ritalin: the Suffolk County, New York study. In: Greenhill LL, Osman BB, editors. Ritalin: theory and patient management. New York: Mary Ann Liebert; 1991. p 187-93.
15. Klein RG, Abikoff H. Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders 1997;2:89-114.
16. Pelham WE, Schnedler RW, Bender ME, Miller J, Nilsson D, Budrow M, and others. The combination of behavior therapy and methylphenidate in the treatment of hyperactivity: a therapy outcome study. In: Bloomingdale LL, editor. Attention deficit disorders Vol 3. London: Pergamon; 1988. p 29-48.
17. Pelham WE, Carlson C, Sams SE, Vallano G, Dixon MJ, Hoza B. Separate and combined effects of methylphenidate and behavior modificatton on boys with attention deficit-hyperactivily disorder in the classroom. J Consult Clin Psychol 1993;61:506-15.
18. Swanson J, MTA Cooperative Group. Qualitative outcome in the MTA study based on severity of ADHD and ODD symptoms: non-parametric analyses of excellent response at the end of treatment. JAm Acad Child Adolesc Psychiatry. Forthcoming.
19. Conners CK, MTA Cooperative Group. Multimodal treatment of ADHD (MTA): an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. Forthcoming.
20. Carlson CL, Pelham WE, Milich R, Dixon MJ. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention deficit-hyperactivity disorder. J Abnorm Child Psychol 1992;20:213-32.
21. Pelham WE, Schnedler RW, Bologna NC, Contreras JA. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within-subject design. J Appl Behav Anal 1980;13:221-36.
22. Pelham WE. Secondary Analyses of psychosocial treatment effects: subgroups and compliance. In: Greenhill L, Chair. The NIMH Multimodal, Multisite Treatment Study for ADHD: posttreatment results. Symposium presented at the annual meeting of the American Psychological Association, Boston, August 1999.
23. Pelham WE, Hinshaw SP, Swanson JM, Gnagy EM, Greiner AR, Hoza B, and others. Behavioral vs. behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol. Forthcoming.
24. Pelham WE, Waschbusch DA. Behavioral interventions in attention deficit/hyperactivity disorder. In: Quay H, Hogan A, editors. Handbook of disruptive behavior disorders. New York: Kluwer Academic/Plenum Publishers; 1999. p 255-78.
25. Pelham WE, Murphy A. Attention deficit and conduct disorders. In: Hersen M, editor. Pharmacological and behavioral treatment: an integrative approach. New York: Wiley; 1986. p 108-48.
26. Stokes TF, Baer DM. An implicit technology of generalization. J Appl Behav Anal 1977;10:349.
27. Jensen P. Behavioral and medication treatments for ADHD: comparisons and combinations. Paper presented at the NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. Washington DC, November 16-18, 1998.
28. Greenhill LL, Halperin HM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999;38:503-12.
29. NIH Consensus Statement. Diagnosis and treatment of attention deficit hyperactivity disorder. Nov 16-18, 1998;16(2):1-37.
30. Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ. Gnagy EM, Chronis AM. and others. A comparison of Ritalin and Adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics 1999;103(4):e43.
31. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano G, Morrisey SM, and others. Once-a-day OROS® methylphenidate versus t.i d. methylphenidate in a laboratory setting. Paper tobe presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry/Canadian Academy of Child Psychiatry, October 1999.